Home Imprint Sitemap Profile News & Events Management Contact us Profile Heidelberg Pharma at a glance: Our facilities situated in the former Max-Planck-Institute in Ladenburg, Germany include 2000 square meters of laboratory space. We are running a dual business model as a pre-clinical CRO and a drug development company. CRO ADC drug development As a pre-clinical CRO we offer explorative pharmacology, drug metabolism and pharmacokinetics (DMPK) analysis and molecular biology. Our core competence is the pre-clinical profiling of small molecules or biologicals destined for the treatment of cancer or inflammatory/autoimmune diseases. As a drug development company we concentrate on combining the targeting properties of antibodies with the effectiveness of an ultra-potent toxin with antibody-drug conjugates (ADC), that are more effective against cancer. Key USP of our technology is the potential to treat multiresistant tumors and ‘dormant or quiescent’ tumor cells, which are regarded as a main reason for metastasis and resistance. Print This Page | Email This Page About us Profile News & Events Management History Contact us Google+ Services General Cancer Inflammation DMPK Molecular biology Quality assurance ADC Technology Technology References Bibliography Investor Investor contact Contact Business Development Service Jobs Directions Unsubscribe from our Service-Newsletter

Home Imprint Sitemap Profile News & Events Management Contact us Contact us * indicates required Salutation: Mrs Mr Name * Company / Organisation Your E-Mail adress * Subject Your message Please answer following question: * 2 plus 3 = ? Print This Page | Email This Page About us Profile News & Events Management History Contact us Google+ Services General Cancer Inflammation DMPK Molecular biology Quality assurance ADC Technology Technology References Bibliography Investor Investor contact Contact Business Development Service Jobs Directions Unsubscribe from our Service-Newsletter

Home Imprint Sitemap Profile News & Events Management Contact us History Print This Page | Email This Page About us Profile News & Events Management History Contact us Google+ Services General Cancer Inflammation DMPK Molecular biology Quality assurance ADC Technology Technology References Bibliography Investor Investor contact Contact Business Development Service Jobs Directions Unsubscribe from our Service-Newsletter